The global Oncology Targeted Therapy market size is predicted to grow from US$ 65370 million in 2025 to US$ 113610 million in 2031; it is expected to grow at a CAGR of 9.6% from 2025 to 2031.
Targeted therapy is a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
This Insight Report provides a comprehensive analysis of the global Oncology Targeted Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.
Key Features
- Comprehensive overview of the Oncology Targeted Therapy market.
- Market shares and growth opportunities by product type, application, key players, and regions.
Segmentation by Type
- Sorafenib
- Lenvatinib
- Regorafenib
- Osimertinib
- Anlotinib
- Alectinib
- Other
Segmentation by Application
- Hospital
- Retail Pharmacy
- Other
Market by Region
- Americas
- APAC
- Europe
- Middle East & Africa
Company's Coverage
- Bayer
- Eisai
- Zelgen
- Cipla
- Natco Pharma
- AstraZeneca
- Novartis
- Roche
- Bristol-Myers Squibb
- Pfizer
- BEACON Pharma
- Jiangxi Shanxiang
- Yao Pharma
- CSPC
- CHIATAI Tianqing
- Simcere
Key Questions Addressed in this Report
- What are the key market trends in Oncology Targeted Therapy?
- Who are the leading companies in the global Oncology Targeted Therapy market?
- What are the growth opportunities for the Oncology Targeted Therapy market?
Frequently Asked Questions
What is the USP of the report? expand_more
Oncology Targeted Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Oncology Targeted Therapy report is categorised based on following features:
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Oncology Targeted Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.